Group 1 - On November 12, Kaisheng New Materials experienced a decline of 1.09% with a trading volume of 983 million yuan, and the net financing purchase amounted to 7.255 million yuan [1] - As of November 12, the total balance of margin trading for Kaisheng New Materials reached 500 million yuan, with a financing balance of 499 million yuan, accounting for 4.51% of the circulating market value, indicating a high level compared to the past year [1] - The company specializes in fine chemical products and new polymer materials, with its main revenue sources being carboxylic chlorides (59.25%), inorganic chemicals (26.23%), and hydroxyl chlorides (13.93%) [1] Group 2 - As of October 20, the number of shareholders for Kaisheng New Materials increased to 35,600, a rise of 13.36%, while the average circulating shares per person decreased by 11.79% to 10,998 shares [2] - For the period from January to September 2025, Kaisheng New Materials reported a revenue of 774 million yuan, reflecting a year-on-year growth of 11.22%, and a net profit attributable to shareholders of 116 million yuan, marking a significant increase of 121.56% [2] - The company has distributed a total of 294 million yuan in dividends since its A-share listing, with 189 million yuan distributed over the past three years [3]

证券日报网讯 11月12日晚间，凯盛新材发布公告称，山东凯盛新材料股份有限公司（以下简称"凯盛新 材"）近日接到控股股东华邦生命健康股份有限公司（以下简称"华邦健康"）书面通知，获悉其非公开 发行的可交换公司债券触发提前赎回的条件，根据《华邦生命健康股份有限公司2025年面向专业投资者 非公开发行科技创新可交换公司债券募集说明书》有关条款约定，华邦健康决定行使发行人赎回选择 权。 （文章来源：证券日报） ...

| 证券代码：301069 | 证券简称：凯盛新材 | 公告编号：2025-053 | | --- | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | | 山东凯盛新材料股份有限公司 关于控股股东非公开发行可交换公司债券 赎回业务的第一次提示性公告 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致， 并保证披露的公司相关信息内容真实、准确、完整，没有虚假记载、误导性陈 述或重大遗漏。 重要提示： 1.债券代码：117227 2.债券简称：25 华邦 EB 3.赎回登记日:2025 年 12 月 9 日 4.赎回资金到账日:2025 年 12 月 10 日 5.赎回价格：人民币 100.0636 元/张（含当期利息，且当期利息含税） 6.债券赎回比例:全部赎回 7.摘牌日:2025 年 12 月 10 日 山东凯盛新材料股份有限公司（以下简称"凯盛新材"）近日接到控股股东 华邦生命健康股份有限公司（以下简称"华邦健康"）书面通知，获悉其非公开 发行的可交换公司债券触发提前赎回的条件，根据《华邦生命健康股份有限公司 2025 年面向专业投资者非公开发行科技创新可交换 ...

| 证券代码：301069 | 证券简称：凯盛新材 | 公告编号：2025-054 | | --- | --- | --- | | 债券代码：123233 | 债券简称：凯盛转债 | | 山东凯盛新材料股份有限公司 关于非公开发行可交换公司债券换股价格 调整的提示性公告 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致， 并保证披露的公司相关信息内容真实、准确、完整，没有虚假记载、误导性陈 述或重大遗漏。 特别提示： 一、可交换公司债券基本情况 山东凯盛新材料股份有限公司（以下简称"公司"）控股股东华邦生命健康 股份有限公司（以下简称"华邦健康"）2025 年面向专业投资者非公开发行科技 创新可交换公司债券（以下简称"本期债券"）于 2025 年 4 月 22 日完成发行， 债券的种类为可交换为公司 A 股股票的公司债券，债券简称"25 华邦 EB"，债 券代码"117227"，发行规模"人民币 6 亿元"，换股期限为自可交换债发行结束 日满 6 个月后的第一个交易日起至可交换债摘牌前一个交易日止，即 2025 年 10 月 23 日至 2028 年 4 月 21 日。 二、可交换债券换股价格 ...

Group 1 - The PEEK materials index experienced a decline of 2.12% during the trading session, with most constituent stocks also falling [1] - Notable declines among constituent stocks included Zhongxin Fluorine Materials, Guoen Co., Xinhang New Materials, Kaisheng New Materials, and Zhaomin Technology, which dropped by 6.08%, 5.75%, 3.53%, 2.90%, and 2.90% respectively [1]

Core Viewpoint - The chemical raw materials sector experienced a rise of 1.67% on November 11, with Aok股份 leading the gains, while the overall market indices showed declines [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 4002.76, down 0.39%, and the Shenzhen Component Index closed at 13289.0, down 1.03% [1]. - Aok股份 saw a significant increase of 20.04%, closing at 11.44, with a trading volume of 1,102,100 shares and a transaction value of 1.184 billion [1]. - Other notable performers included 等瑞矿业, 三祥新材, and 三重股份, which rose by 10.03%, 10.01%, and 9.99% respectively [1]. Group 2: Capital Flow - The chemical raw materials sector had a net inflow of 304 million in main funds, while speculative funds saw a net outflow of 352 million, and retail investors had a net inflow of 48.09 million [2]. - Aok股份 had a main fund net inflow of 195 million, but speculative funds experienced a net outflow of 118 million [3]. - 鲁西化工 and 红星发展 also showed significant main fund inflows of 79.49 million and 71.41 million respectively [3].

Core Viewpoint - The company, Shandong Kaisheng New Materials Co., Ltd., has announced its profit distribution plan for the first three quarters of 2025, which includes a cash dividend of 0.50 RMB per 10 shares and no stock bonus, based on a total share capital of 420,647,429 shares as of September 30, 2025 [1][3][17]. Profit Distribution Plan - The profit distribution plan was approved by the company's board on October 22, 2025, and will distribute a total cash dividend of 21,032,371.45 RMB [1][3]. - The cash dividend will be distributed to all shareholders registered by the close of trading on November 17, 2025, with the ex-dividend date set for November 18, 2025 [3][4]. Share Capital Changes - As of the announcement date, the company's total share capital has increased from 420,647,429 shares to 420,647,487 shares, with the profit distribution plan remaining unchanged [2]. Taxation Details - The cash dividend will be subject to different tax rates based on the type of shareholder, with specific provisions for Hong Kong investors and domestic investors holding different types of shares [3]. Convertible Bond Adjustment - Following the profit distribution, the conversion price of the company's convertible bonds (Kaisheng Convertible Bonds) will be adjusted from 20.01 RMB per share to 19.96 RMB per share, effective from November 18, 2025 [6][18].

Core Viewpoint - The PEEK materials index experienced a 2.01% increase, indicating a broad upward trend among constituent stocks, with notable gains from several companies [2] Group 1: Stock Performance - Kaisheng New Materials saw a significant rise of 13.71% [2] - Wind Power Co., Guoen Co., Zhongxin Fluorine Materials, and Zhaomin Technology reported notable increases of 3.67%, 3.31%, 2.69%, and 2.38% respectively [2]

Group 1 - The chemical raw materials sector experienced a significant upward movement on November 11, with Haike Xinyuan rising over 12% [2] - Sanfu Co., Ltd. reached its daily limit up, indicating strong investor interest [2] - Other stocks such as Huaheng Biological, Jinjing Technology, Hualitai, Heyuan Gas, and Kaisheng New Materials also saw gains, reflecting a broader positive trend in the sector [2]

分组1 - Shengnuo Biotech announced a cash dividend of RMB 0.03176 per share, with the record date on November 14, 2025, and the ex-dividend date on November 17, 2025 [1] - Jiangsu Guotai declared a cash dividend of RMB 1.70 per 10 shares (including tax), with the record date on November 17, 2025, and the ex-dividend date on November 18, 2025 [1] - Dabeinong issued a cash dividend of RMB 0.30 per 10 shares (including tax), with the record date on November 17, 2025, and the ex-dividend date on November 18, 2025 [1] 分组2 - Rongmei Co. announced a cash dividend of RMB 1.32 per 10 shares (including tax), with the record date on November 17, 2025, and the ex-dividend date on November 18, 2025 [2] - Kaisheng New Materials declared a cash dividend of RMB 0.50 per 10 shares (including tax), with the record date on November 17, 2025, and the ex-dividend date on November 18, 2025 [2] - Guilin Sanjin issued a cash dividend of RMB 2.00 per 10 shares (including tax), with the record date on November 18, 2025, and the ex-dividend date on November 19, 2025 [2] 分组3 - Longhua New Materials announced a cash dividend of RMB 0.70 per 10 shares (including tax), with the record date on November 18, 2025, and the ex-dividend date on November 19, 2025 [3] - Mingtai Aluminum declared a cash dividend of RMB 0.10 per share (including tax), with the record date on November 18, 2025, and the ex-dividend date on November 19, 2025 [3]